What's New

2017-08-13

New CyberKnife M6 Service at HKSH for Cancer Patients Shorter Treatment Time, Fewer Side Effects and Improved Patient Outcomes

(13 August 2017, Hong Kong) Hong Kong Sanatorium & Hospital (HKSH) has brought in a new cancer treatment option for its patients with the installation of CyberKnife M6, the latest model in Asia, which shortens treatment time, targets the affected area with a high degree of precision and minimises radiation dosage to normal organs.

The non-invasive, non-surgical radiation treatment option is applicable to a broad range of tumours in the body, including lung, liver, brain, spine, prostate, pancreas and kidney. Since its introduction in May this year, more than 40 patients with lung cancer and tumours in spine and brain, have been treated. Some prostate cancer and liver cancer patients have also been treated with satisfactory results.

Assistant Medical Superintendent and Director of Comprehensive Oncology Centre of the Hospital, Dr. Raymond LIANG Hin Suen, noted that aging population in the local community has posed challenges to the healthcare system and the number of new cancer cases has been on the increase. “The incidence of cancer has been rising over the past 10 years, reaching to a record high in 2014 with almost 30,000 new cases a year. To take on the challenge, healthcare professionals around the world are looking for treatment options that can achieve high clinical efficiency with fewer side effects. The introduction of CyberKnife M6 at the Hospital provides an additional option to Hong Kong patients.”

Please click here for more information.